Application of a Gamma Model of Absorption to Oral Cyclosporin
- 1 January 2001
- journal article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 40 (5) , 375-382
- https://doi.org/10.2165/00003088-200140050-00004
Abstract
Background: Some drugs, such as cyclosporin, exhibit flat and delayed absorption profiles, with a correlation between the delay and the peak width. Such profiles can be described by an absorption model in which the absorption rate is derived from a gamma distribution (of which the classical first-order absorption model is a special case). Objective: To develop a model for the pharmacokinetics of extravascular administration of cyclosporin and apply it to a study of the pharmacokinetics of cyclosporin microemulsion in stable renal transplant recipients. Patients and participants: 21 renal transplant patients receiving oral cyclosporin microemulsion 75 to 175mg twice daily. Methods: The equation of the plasma concentration-time curve after oral administration was expressed as a convolution product between the absorption rate and a multi-exponential impulse response. The convolution integral was computed analytically and expressed in terms of the incomplete gamma function. Cyclosporin was assayed by liquid chromatography/mass spectrophotometry. The model was fitted by nonlinear regression, using a specially developed program. Results: The gamma model yielded a good fit in all of the 21 patients studied. Attempts to fit the same data by a classical exponential with lag-time model failed in most patients. Conclusions: This model could simplify the Bayesian monitoring of cyclosporin therapy.Keywords
This publication has 23 references indexed in Scilit:
- Transit Compartments versus Gamma Distribution Function To Model Signal Transduction Processes in PharmacodynamicsJournal of Pharmaceutical Sciences, 1998
- Challenges in Cyclosporine Therapy: The Role of Therapeutic Monitoring by Area Under the Curve MonitoringTherapeutic Drug Monitoring, 1995
- CONSISTENT ABSORPTION OF CYCLOSPORINE FROM A MICROEMULSION FORMULATION ASSESSED IN STABLE RENAL TRANSPLANT RECIPIENTS OVER A ONE-YEAR STUDY PERIODTransplantation, 1995
- Population Pharmacokinetic ModelsTherapeutic Drug Monitoring, 1994
- Cyclosporine Disposition and Metabolite Profiles in Renal Transplant Patients Receiving a Microemulsion FormulationTherapeutic Drug Monitoring, 1994
- Within-Day Consistency in Cyclosporine Pharmacokinetics from a Microemulsion Formulation in Renal Transplant PatientsTherapeutic Drug Monitoring, 1994
- Evaluation of a Bayesian Approach to the Pharmacokinetic Interpretation of Cyclosporin Concentrations in Renal Allograft RecipientsTherapeutic Drug Monitoring, 1994
- Bayesian Estimation of Cyclosporine Clearance in Bone Marrow GraftTherapeutic Drug Monitoring, 1990
- Cyclosporine Monitoring in Renal TransplantationTherapeutic Drug Monitoring, 1989
- A Simplex Method for Function MinimizationThe Computer Journal, 1965